A medical crusade devoted to the pharmaceutical and surgical alteration of children’s bodies is projected to become a $5 billion industry in the United States by 2030, according to a market research report by Grand View Research (pdf).
However, this lucrative commitment to the gender-affirming care model is not without dissent.
Though it may seem a majority are in lockstep with transitioning children, there remain physicians who continue to speak out, and their opposition is supported by a withdrawal from the model abroad after it’s been deduced to cause more harm than good.
Drs. Patrick Lappert and Stanley Goldfarb both spoke with The Epoch Times, addressing what is perpetuating the race to prescribe drugs and operate on adolescents and why America’s unquestioning embrace of gender ideology differs from European countries….